A tetrawalled
and an octawalled molecular umbrella conjugate of
amphotericin B (AmB) have been synthesized. Both conjugates exhibit
high water solubility, a low tendency to aggregate, negligible hemolytic
activity at 100 μM, and an ability to release a derivative of
AmB under reducing conditions that exhibits high antifungal activity.
Whereas the larger, octawalled conjugate shows slight adsorption to
liposomal membranes and an ability to cross them by passive transport,
the tetrawalled analogue shows significant adsorption and much lower
bilayer transport activity. The potential of molecular umbrella–AmB
conjugates as therapeutic agents is briefly discussed.